U.S. stocks rose Friday; Humana jumped 12.3% after improved 2027 Medicare Advantage ratings and reaf

Analysts initiated coverage: Overweight GNRC ($303), Buy ENTG ($200) and VYLR ($87), Neutral SPOT ($

Jefferies analyst Matthew Stanton initiates coverage on Twist Bioscience (NASDAQ:TWST) with a Hol

Quantum-Si (NASDAQ: QSI - Get Free Report) and Twist Bioscience (NASDAQ: TWST - Get Free Report) are

Barclays analyst Luke Sergott maintains Twist Bioscience (NASDAQ:TWST) with a Overweight and rais

Cathie Wood's ARK dumps $18M of Twist Bioscience while buying Recursion, Veracyte and Intellia,

Twist Bioscience Corporation (NASDAQ: TWST - Get Free Report)'s share price dropped 9.7% during mid-

Cathie Wood defends ARKK's 15% drop vs QQQ's 112% 5-year gain, calling it an 'incorrect

Twist Bioscience (NASDAQ:TWST) has outperformed the market over the past 5 years by 3.68% on an annu

Guggenheim analyst Subbu Nambi maintains Twist Bioscience (NASDAQ:TWST) with a Buy and raises the

Strong performance across the healthtech sector over the past two quarters has sparked renewed marke

Leerink Partners analyst Puneet Souda maintains Twist Bioscience (NASDAQ:TWST) with a Outperform

Twist Bioscience Corp. (NASDAQ:TWST) shares are trading lower Friday, pulling back after touching a

Twist Bioscience shares are trading lower Friday, pulling back after touching a fresh 52-week high n

Louis says buy the AI dip

The biotech will both contribute to and draw from its findings. It'll also earn revenue from its par

U.S. stocks rose; Vicor jumped 13.5% on a new license, while Generac surged 19.6% on an Amazon deal.

Twist Bioscience Corporation (NASDAQ:TWST) on Wednesday announced an agreement with Lilly TuneLab, a

Twist Bioscience joins Eli Lilly's TuneLab platform, supplying high-throughput antibody data to

U.S. stocks mixed as Nasdaq rises; LuxExperience jumps 13.5% on strong sales, while Einride, Forgent

[url="]Twist Bioscience Corporation[/url] (NASDAQ: TWST), a mid-cap growth and value biotech company

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap

BWS Financial analyst Hamed Khorsand initiates coverage on Twist Bioscience (NASDAQ:TWST) with a

If AI and robotics suddenly feel like they are moving faster, August gave investors plenty of eviden

UBS analyst Doug Schenkel initiates coverage on Twist Bioscience (NASDAQ:TWST) with a Neutral rat

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap

Brandywine Managers LLC acquired a new position in shares of Twist Bioscience Corporation (NASDAQ: T

Deutsche Bank AG acquired a new stake in Twist Bioscience Corporation (NASDAQ: TWST) in the undefine

Twist Bioscience Corporation is rated Hold, as its $9.5bn valuation appears disconnected from curren

Twist Bioscience Corp (NASDAQ:TWST) shares surged Wednesday after Anthropic named the company an ind

TWST shares surge after Anthropic names the company an independent evaluator in a new AI-driven prot

Twist Bioscience (TWST) stock jumped 17% after Anthropic chose the firm to test AI-designed proteins

Dow Jones up 200 points on Wed. Estee Lauder & other top stocks record gains after reporting str

Anthropic is preparing what could be the largest IPO of 2026, and it's telling investors the pitch g

On August 07, 2026, Twist Bioscience Corp (TWST) shares rose by 6.0%, bringing the current price to

Twist Bioscience Corporation (NASDAQ: TWST - Get Free Report)'s share price shot up 10.3% during mid

Piper Sandler analyst David Westenberg maintains Twist Bioscience (NASDAQ:TWST) with a Overweight

Twist Bioscience's stock has surged in 2026 on the back of improved growth and growing optimism abou

Twist Bioscience Corporation (Nasdaq: TWST) (“Twist”), a mid-cap growth and value biotech compan

Baird analyst Catherine Ramsey maintains Twist Bioscience (NASDAQ:TWST) with a Outperform and rai

Twist Bioscience (NASDAQ: TWST) stock is up on strong Q3 results and raised guidance. AI drug discov

Twist Bioscience (NASDAQ:TWST) raises FY2026 sales outlook from $442.000 million-$447.000 million to

Twist Bioscience (NASDAQ:TWST) sees Q4 sales of $123.000 million-$124.000 million vs $117.546 millio

Canaccord Genuity analyst Kyle Mikson maintains Twist Bioscience (NASDAQ:TWST) with a Buy and rai

Evercore ISI Group analyst Vijay Kumar downgrades Twist Bioscience (NASDAQ:TWST) from Outperform

Guggenheim analyst Subbu Nambi maintains Twist Bioscience (NASDAQ:TWST) with a Buy and raises the

Barclays analyst Luke Sergott maintains Twist Bioscience (NASDAQ:TWST) with a Overweight and rais

https://www.sec.gov/Archives/edgar/data/1581280/000110465926075726/tm2617605-1_s3asr.htm

TD Cowen analyst Brendan Smith maintains Twist Bioscience (NASDAQ:TWST) with a Buy and raises the

Canaccord Genuity analyst Kyle Mikson initiates coverage on Twist Bioscience (NASDAQ:TWST) with a